News | Magnetic Resonance Imaging (MRI) | March 15, 2017

Toshiba Vantage Galan 3T MRI Tapped for UCI Brain Trauma Research

Study seeks to identify precursors to CTE in high school football players

UCI, University of California Irvine, brain trauma research, CTE, Toshiba, Vantage Galan 3T MRI

March 15, 2017 — Researchers at the University of California Irvine now have access to Toshiba Medical’s most advanced magnetic resonance (MR) technology for their cutting-edge neurology work investigating cerebral microbleeds (CMB) in high school football players as a potential precursor to chronic traumatic encephalopathy (CTE). As part of its ongoing, first-of-its-kind study to identify early signs of brain trauma in young athletes, UCI doctors will now leverage Toshiba Medical’s Vantage Galan 3T MR system as a key diagnostic tool.

“Young athletes competing in high-impact activities face many potential risks of head injury, but Toshiba Medical’s Galan 3T MR system may enable us to identify these risks and make greater strides in our understanding and treatment of early head trauma,” said Mark Fisher, M.D., UCI professor of neurology and study lead researcher. “We are very excited at the prospect of marrying healthcare and technology to provide better treatment for athletes today and improved preventative care in the years to come.”

The UCI study is investigating the use of non-contrast MRI as a safe and noninvasive way to examine young athletes and other patients for early signs of CTE, a degenerative disease found in those who suffer head trauma, and a well-documented consequence of sub-concussive head injury. Evaluations of local high school student volunteers include 100 test subjects (football players) and 50 control subjects (non-football players), and the research is supported by the UCI Exercise Medicine and Sport Sciences Initiative (EMSSI). Toshiba Medical has provided application training to UCI researchers to operate the Vantage Galan 3T. UCI is also leveraging the system for imaging of the cervical spine to screen for early neck injury.

The Vantage Galan 3T was chosen for its ability to conduct quick, comfortable and high-quality neuro exams. Designed to increase signal-to-noise ratio (SNR) by up to 20 percent, the system allows for faster sampling and higher resolution images thanks to PURERF and Saturn technologies. This, combined with the ability to stack protocol sequences, results in quick neuro exams enabling researchers to produce higher resolution images for myriad neuro exams in under five minutes. The system’s 71 cm aperture expands access to large and claustrophobic patients, while Pianissimo Zen technology reduces sound during acquisition by 99 percent.

For more information: www.medical.toshiba.com

Related Content

Bay Labs and Northwestern Medicine Enroll First Patient in AI Echocardiography Study
News | Cardiovascular Ultrasound | November 19, 2018
Medical artificial intelligence (AI) company Bay Labs and Northwestern Medicine announced that the first patient has...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...